Adena Healthcare Collaborative, LLC

ACO Name and Location

Adena Healthcare Collaborative, LLC
272 Hospital Road
Chillicothe, OH 45601

ACO Primary Contact

Joseph Zakrzewski
740-773-7398
jzakrzewski@adena.org

Organizational Information

ACO participants:

Adena Medical Group, LLC N

ACO governing body:

Member	Title/position	Member’s Voting Power	Membership Type	ACO Participant Legal Business Name/DBA if applicable
Jim McManus	Chairperson	20%	ACO Participant Representative	Adena Health System
Devin Zakrzewski		20%	ACO Participant Representative	Adena Health System
Katherine Edrington		20%	ACO Participant Representative	Adena Health System
Robert Violette, MD		20%	ACO Participant Representative	Adena Medical Group, LLC
William Beatty		20%	Medicare Beneficiary

Key ACO clinical and administrative leadership:

Joseph Zakrzewski - ACO Executive
Robert Violette, MD - Medical Director
Kristin Boggs - Compliance Officer
Jessica Parsons - Quality Assurance/Improvement Officer

Associated committees and committee leadership:

Committee Name	Committee Leader Name and Position
Finance and Clinical Quality Committee	Dr. Robert Violette, Chair
Data and Analytics Committee	Jessica Parsons and Rachel Collier, Co-Chairs

Types of ACO participants, or combinations of participants, that formed the ACO:

Critical Access Hospital (CAH) billing under Method II
Hospital employing ACO professionals
Partnerships or joint venture arrangements between hospitals and ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

Second Agreement Period

Performance Year 2021, $0
Performance Year 2020, $0
Performance Year 2019, $0
Performance Year 2018, $0

First Agreement Period

Performance Year 2017, $0
Performance Year 2016, $4,453,320
Performance Year 2015, $2,551,721

Shared Savings Distribution

Second Agreement Period

Performance Year 2021
Proportion invested in infrastructure: N/A
Proportion invested in redesigned care processes/resources: N/A
Proportion of distribution to ACO participants: N/A
Performance Year 2020
Proportion invested in infrastructure: N/A
Proportion invested in redesigned care processes/resources: N/A
Proportion of distribution to ACO participants: N/A
Performance Year 2019
Proportion invested in infrastructure: N/A
Proportion invested in redesigned care processes/resources: N/A
Proportion of distribution to ACO participants: N/A
Performance Year 2018
Proportion invested in infrastructure: N/A
Proportion invested in redesigned care processes/resources: N/A
Proportion of distribution to ACO participants: N/A

First Agreement Period

Performance Year 2017
Proportion invested in infrastructure: N/A
Proportion invested in redesigned care processes/resources: N/A
Proportion of distribution to ACO participants: N/A
Performance Year 2016
Proportion invested in infrastructure: 28%
Proportion invested in redesigned care processes/resources: 8%
Proportion of distribution to ACO participants: 64%
Performance Year 2015
Proportion invested in infrastructure: 25%
Proportion invested in redesigned care processes/resources: n/a
Proportion of distribution to ACO participants: 75%

Quality Performance Results

2021 Quality Performance Results:

Measure #	Measure Name	Rate	ACO Mean
CAHPS-1	Getting Timely Care, Appointments, and Information	89.19	84.67
CAHPS-2	How Well Providers Communicate	95.74	93.56
CAHPS-3	Patient’s Rating of Provider	94.65	92.19
CAHPS-4	Access to Specialists	82.20	78.80
CAHPS-5	Health Promotion and Education	56.94	61.61
CAHPS-6	Shared Decision Making	57.20	60.89
CAHPS-7	Health Status and Functional Status	69.60	71.78
CAHPS-8	Care Coordination	89.08	85.66
CAHPS-9	Courteous and Helpful Office Staff	94.33	91.88
CAHPS-11	Stewardship of Patient Resources	23.51	24.71
001	Diabetes: Hemoglobin A1c (HbA1c) Poor Control	13.28	12.46
134	Preventative Care and Screening: Screening for Depression and Follow-up Plan	39.50	74.38
236	Controlling High Blood Pressure	69.05	74.87
318	Falls: Screening for Future Fall Risk	96.41	87.03
110	Preventative Care and Screening: Influenza Immunization	79.25	80.52
226	Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention	100.00	80.97
113	Colorectal Cancer Screening	66.56	73.63
112	Breast Cancer Screening	60.00	75.11
438	Statin Therapy for the Prevention and Treatment of Cardiovascular Disease	80.90	84.24
370	Depression Remission at Twelve Months	0.00	15.50
479	Hospital-Wide, 30-Day, All-Cause Unplanned Readmissions (HWR) Rate for MIPS Groups	0.1595	0.1540
MCC1	All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions for ACOs (MCC)	35.69	33.99

Please note, the Quality ID #: 370 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size.

For previous years’ Financial and Quality Performance Results, please visit: data.cms.gov.